Scientific peer review of wildlife toxicity assessments (WTAS)

Ended Purchase Order Awarded Last action

Contract number
W81XWH22P0197
Awardee
Awarding agency
Obligated
$107,432

Award facts

Opportunity
Contract value 71% obligated
  • $107,431.76 Current, with exercised options
  • $150,714.32 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
New Hill, NC 27562, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Vendor Address Change P00003 · Scientific peer review services of wildlife toxicity assessments $42,022
Exercise an Option P00002 · Scientific peer reviews of wildlife toxicity assessments $40,798
Exercise an Option P00001 · Scientific peer review $18,612
Original award $6,000

About this award

Raptor Pharm & Tox, LTD, a minority-owned small disadvantaged business based in New Hill, North Carolina, was awarded a $150.7K firm fixed-price contract by the Defense Health Agency's U.S. Army Medical Research Acquisition Activity (USAMRAA) on September 28, 2022. The contract, which has no set-aside designation, calls for scientific peer review services of Wildlife Toxicity Assessments (WTAs) and extends through September 28, 2027. Under this contract, Raptor Pharm & Tox will identify subject matter experts, coordinate external reviewers, and compile comprehensive peer review documentation to support the U.S. Army Public Health Center's toxicological evaluation capabilities. The work will be performed in New Hill, North Carolina.

This award reflects the Defense Health Agency's commitment to leveraging specialized scientific expertise for its public health research mission. Raptor Pharm & Tox has established itself as a competitive technical service provider in the federal sector, securing multiple contract awards across both civilian and defense agencies for expert witness and peer review work. The company's successful competition in this open procurement demonstrates its capability to deliver high-value scientific services without reliance on set-aside programs, positioning it as a qualified partner for complex toxicological assessment reviews that support Army medical and public health objectives.

Quick answers

Who was awarded contract W81XWH22P0197?

W81XWH22P0197 was awarded to Raptor Pharm & Tox, LTD by Defense Health Agency (Department of Defense) on September 28, 2022.

How much is contract W81XWH22P0197 worth?

The government has obligated $107,432 on W81XWH22P0197. Its potential value, with all options, is $150,714.

Was contract W81XWH22P0197 competed?

The extent of competition for W81XWH22P0197 was competed under sap. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award